Odyssean LLC’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
Odyssean LLC's ADMA Position: Q3 2026 in Review
Odyssean LLC increased its ADMA Biologics (ADMA) stake by 106% in Q3 2026, buying an estimated $1.22M and bringing the position to 256,607 shares worth $2.57M. The position accounts for 0.3% of the portfolio, ranked #149.
Odyssean LLC first reported a position in ADMA in Q4 2025 and has held it in 3 quarters since. 330 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- Odyssean LLC held 256,607 shares of ADMA Biologics worth $2.57M as of Q3 2026.
- Odyssean LLC bought 132,109 ADMA Biologics shares in Q3 2026, an estimated $1.22M.
- ADMA Biologics made up 0.3% of Odyssean LLC's portfolio in Q3 2026, its #149 holding.
- Odyssean LLC first reported a position in ADMA Biologics in Q4 2025 and has held it in 3 quarters since.
- 330 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.